Evolent Health, Inc (EVH): Price and Financial Metrics
GET POWR RATINGS... FREE!
EVH POWR Grades
- EVH scores best on the Growth dimension, with a Growth rank ahead of 83.89% of US stocks.
- The strongest trend for EVH is in Stability, which has been heading up over the past 31 weeks.
- EVH ranks lowest in Sentiment; there it ranks in the 15th percentile.
EVH Stock Summary
- EVH's went public 6.04 years ago, making it older than merely 21.47% of listed US stocks we're tracking.
- Of note is the ratio of Evolent Health Inc's sales and general administrative expense to its total operating expenses; only 24.02% of US stocks have a lower such ratio.
- With a year-over-year growth in debt of -18.39%, Evolent Health Inc's debt growth rate surpasses 25.43% of about US stocks.
- Stocks that are quantitatively similar to EVH, based on their financial statements, market capitalization, and price volatility, are PTEN, CSSE, KRP, NBEV, and GIFI.
- Visit EVH's SEC page to see the company's official filings. To visit the company's web site, go to www.evolenthealth.com.
EVH Price Target
For more insight on analysts targets of EVH, see our EVH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $25.57 | Average Broker Recommendation | 1.55 (Moderate Buy) |
EVH Stock Price Chart Interactive Chart >
EVH Price/Volume Stats
| Current price | $19.72 | 52-week high | $22.35 |
| Prev. close | $19.91 | 52-week low | $5.98 |
| Day low | $19.59 | Volume | 1,100,500 |
| Day high | $20.38 | Avg. volume | 553,353 |
| 50-day MA | $19.85 | Dividend yield | N/A |
| 200-day MA | $16.77 | Market Cap | 1.71B |
Evolent Health, Inc (EVH) Company Bio
Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.
Latest EVH News From Around the Web
Below are the latest news stories about Evolent Health Inc that investors may wish to consider to help them evaluate EVH as an investment opportunity.
Evolent Health, Inc Consensus Indicates Potential 38.3% UpsideEvolent Health, Inc found using ticker (EVH) now have 7 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 31 and 20 and has a mean target at 25.57. With the stocks previous close at 18.49 this would imply there is a potential upside of 38.3%. The day 50 moving average is 19.88 and the 200 day MA is 18.59. The company has a market capitalisation of $1,644m. Find out more information at: /> [stock_market_widget type="chart" symbol="EVH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment pro... |
Evolent Health, Inc Consensus Indicates Potential 31.6% UpsideEvolent Health, Inc with ticker code (EVH) now have 7 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 31 and 20 and has a mean target at 25.57. With the stocks previous close at 19.43 this would indicate that there is a potential upside of 31.6%. The 50 day MA is 20.07 while the 200 day moving average is 18.4. The company has a market cap of $1,684m. Find out more information at: /> [stock_market_widget type="chart" symbol="EVH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment prov... |
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 27% UndervaluedIn this article we are going to estimate the intrinsic value of Evolent Health, Inc. ( NYSE:EVH ) by projecting its... |
Evolent Health, Inc Consensus Indicates Potential 30.8% UpsideEvolent Health, Inc with ticker code (EVH) now have 7 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 29 and 20 and has a mean target at 25.29. With the stocks previous close at 19.34 this would imply there is a potential upside of 30.8%. The 50 day moving average now sits at 20.16 and the 200 day MA is 18.17. The market capitalisation for the company is $1,642m. Visit the company website at: /> [stock_market_widget type="chart" symbol="EVH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, S... |
Evolent Health to Participate in Upcoming Investor ConferenceEvolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer and Co-Founder Seth Blackley and Chief Financial Officer John Johnson will participate in an upcoming investor conference. |
EVH Price Returns
| 1-mo | 2.23% |
| 3-mo | -4.78% |
| 6-mo | 27.89% |
| 1-year | 213.51% |
| 3-year | -17.66% |
| 5-year | 19.52% |
| YTD | 23.02% |
| 2020 | 77.13% |
| 2019 | -54.64% |
| 2018 | 62.20% |
| 2017 | -16.89% |
| 2016 | 22.21% |
Continue Researching EVH
Want to do more research on Evolent Health Inc's stock and its price? Try the links below:Evolent Health Inc (EVH) Stock Price | Nasdaq
Evolent Health Inc (EVH) Stock Quote, History and News - Yahoo Finance
Evolent Health Inc (EVH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...